Gardasil Approval History
- FDA approved: Yes (First approved June 8th, 2006)
- Brand name: Gardasil
- Generic name: human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant
- Company: Merck & Co., Inc.
- Treatment for: Human Papillomavirus Prophylaxis
Gardasil (human papillomavirus vaccine) is a recombinant vaccine indicated for the prevention of cervical, vulvar, and vaginal cancers caused by human papillomavirus (HPV) in girls and women 9 through 26 years of age. Gardasil is also approved for the prevention of genital warts caused by HPV types 6 and 11 in boys and men 9 through 26 years of age.
Development History and FDA Approval Process for Gardasil
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.